Related references
Note: Only part of the references are listed.Endomyocardial biopsy in the clinical context: current indications and challenging scenarios
Aldostefano Porcari et al.
HEART FAILURE REVIEWS (2023)
Transthyretin cardiac amyloidosis
Aldostefano Porcari et al.
CARDIOVASCULAR RESEARCH (2023)
Low QRS Voltages in Cardiac Amyloidosis Clinical Correlates and Prognostic Value
Alberto Cipriani et al.
JACC: CARDIOONCOLOGY (2022)
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Pablo Garcia-Pavia et al.
EUROPEAN HEART JOURNAL (2021)
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies
Giada Bianchi et al.
JACC: CARDIOONCOLOGY (2021)
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
E. Kastritis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
Melanie Bezard et al.
PLOS ONE (2021)
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Pablo Garcia-Pavia et al.
EUROPEAN HEART JOURNAL (2021)
Diagnostic imaging of cardiac amyloidosis
Ana Martinez-Naharro et al.
NATURE REVIEWS CARDIOLOGY (2020)
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis
Maria Beatrice Musumeci et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Cardiac amyloidosis: do not forget to look for it
Aldostefano Porcari et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2020)
Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis
Yusuke Kimishima et al.
INTERNATIONAL HEART JOURNAL (2019)
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
Omar K. Siddiqi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2018)
Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure
Brett W. Sperry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
AL (Light-Chain) Cardiac Amyloidosis A Review of Diagnosis and Therapy
Rodney H. Falk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
Shaji Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)